“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”
Bio Spectrum|September 2021
Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;
Sanjiv Das

GVK Bio is now known as Aragen. How is the name change going to have an impact on the brand?

The re-branding exercise has given us an opportunity to re-discover ourselves as an organisation and build upon it. The company has grown from strength to strength over the last 20 years. While our values remain the same, it is now aligned to the new brand promise and purpose, something that is imbibed by each and every employee of the organisation. This rebranding initiative enabled us to streamline and bring in a clear focus to our vision for success. Aragen is a name known for its scientific expertise and customer-centric culture in the West. We are now investing in branding around the name – our initial feedback from both current and prospective customers has been very positive. They love our new identity and our renewed purpose and promise. The number of positive responses in the social media from all our internal and external stakeholders is a testimony to the liking of our new identity. This new brand identity is well poised to launch Aragen into this exciting future.

What are the plans in store following the recent investment by Goldman Sachs?

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BIO SPECTRUMView All

How Tech Innovations Impact Cardiac Care

Cardiac care has seen a transformation over the years with technology playing an important role. Armed with Artificial intelligence (AI) and machine learning (ML), cardiac care providers, with the right technology, have received the right impetus to revolutionise treatment mechanisms. Let us delve into the new technologies which the industry is offering to mankind and decipher the way forward.

6 mins read
Bio Spectrum
September 2021

Mynvax Offers ‘Warm Vaccine' For COVID-19

Biotech startup Mynvax, incubated at the Indian Institute of Science (IISc) in Bengaluru, has developed heat-tolerant COVID-19 vaccine formulations.

1 min read
Bio Spectrum
September 2021

“R&D outsourcing has become a ‘must have' than ‘good-to have' strategy”

Aragen Life Sciences (formerly GVK BIO), a leading contract research and development organisation headquartered in Hyderabad, is marking its transition to a new brand identity in its 20th year. Established in 2001, the company is poised for growth in the outsourced discovery, development, and manufacturing services sector across both large and small molecule platforms with new investments and collaborations. In conversation with BioSpectrum, Manni Kantipudi, Chief Executive Officer, Aragen Life Sciences, Hyderabad reveals more about the company’s recent rebranding and growth plans. Edited excerpts;

4 mins read
Bio Spectrum
September 2021

Premas Biotech to commercialise VLP vaccine tech against Delta variant

Gurugram-based Premas Biotech has signed a licensing deal with Oravax Medical for the development and commercialisation of its virus-like-particle COVID-19 vaccine technology.

1 min read
Bio Spectrum
September 2021

SARS-CoV-2: A Biochemical Treatise on its Past, Present & Future

The SARS-CoV-2 pandemic is unprecedented but equally unprecedented is the contribution of scientists who have helped us in understanding the mechanisms by which it infects human beings and also, developing a variety of vaccines to protect the masses, in a year’s time, which can be called truly groundbreaking. This article gives an overview of the progress made by scientists around the world working round the clock in developing an understanding of the SARS-CoV-2 evolution and COVID-19 disease pathogenesis, and also makes an attempt to suggest the possible ways of coping with this pandemic if we have to co-exist with it forever!

4 mins read
Bio Spectrum
September 2021

Merck launches Pergoveris Pen for fertility treatment in India

Merck Specialties, the healthcare business of Merck in India, has launched Pergoveris Pen for advanced infertility treatment in India.

1 min read
Bio Spectrum
September 2021

GUNG-HO PHARMA R&D INVESTMENTS SURPASS $3B

While the pharmaceutical industry helped combat COVID-19, from R&D actions on potential treatment strategies to balancing the medicines supply chain in the time of crisis, it struggled to maintain the natural market flow. As a result, many pharma companies had to abort some of their ongoing R&D investment plans. However for FY20-21, the average R&D expenses constituted 7.2 per cent of the total revenues of the pharma companies, with Lupin, Alembic Pharma and Dr. Reddy’s spending more than others. The cumulative R&D expenditure of the leading 10 pharma companies has been around Rs 10,627 crore ($1.43 billion) in the previous fiscal. This figure eventually reaches an approximate amount of Rs 22,500 crore ($3.03 billion) after considering the cumulative expenditure by other small and medium players of the India pharma industry.

10+ mins read
Bio Spectrum
September 2021

Glenmark ties up with SaNOtize to commercialise COVID-19 nasal spray

Mumbai-based Glenmark Pharmaceuticals and Canadian biotech firm SaNOtize Research & Development Corporation

1 min read
Bio Spectrum
September 2021

CEPI prioritises Rift Valley fever vax

Sep 01, Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) has signed an implementing partner agreement with Integrum Scientific (US) as part of its ongoing efforts to combat Rift Valley fever (RVF)—one of its priority diseases with epidemic potential.

1 min read
Bio Spectrum
September 2021

3D printing moulds healthcare innovations

Pharmaceuticals, bio-medicine, aviation, and automobiles industries have rapidly adopted 3D printing over the years, worldwide, to develop new solutions and prototypes. It is also helping many industries, healthcare, in particular, increase productivity. Despite all its advantages, 3D printing technology is currently posing a number of challenges in the market such as initial costs, limitation to the metals and plastics used for 3D printing, lack of policy standardisation, etc.

7 mins read
Bio Spectrum
September 2021
RELATED STORIES

The Healthy Habit of Sauca

How cultivating cleanliness inside and out-can bring you peace of mind.

5 mins read
Yoga Journal
Spring 2022

BELLANDUR LAKE FROTH - Debasish Ghosh

Bangalore, India, was once known for its interconnected lake systems, which provided a reliable water source. As the city grew, these lakes have encroached, and the water became polluted day by day. The largest, Bellandur Lake, now carry huge volumes of snowy froth, which block the adjacent canals.

2 mins read
Lens Magazine
October 2020

K'taka revenue intelligence sleuths smash wildlife smuggling racket

THE Directorate of Revenue Intelligence (DRI), Bengaluru, has busted an international wildlife syndicate which trafficked endangered wildlife species though mobile apps, in a massive operation codenamed 'Kalki'.

1 min read
The Morning Standard
January 28, 2023

No new variants found in genomic testing

THE third genomic testing report released this week has shown no new variants of Covid-19 in the positive samples that were collected from across the city and the airport.

1 min read
The Morning Standard
January 27, 2023

Are millets really the only grains you need?

While millets are great for you, blindly replacing the rice and wheat in your pantry with vast quantities of millets is inadvisable

6 mins read
Mint Mumbai
January 21, 2023

'Leasing of retail space up 21% in 2022 across 8 cities'

Leasing of retail real estate space during last year rose 21 percent to 4.7 million square feet across eight major cities mainly on rising demand from Food and Beverage (F&B), fashion and apparel retailers, according to CBRE India.

2 mins read
Millennium Post Delhi
January 20, 2023

DEVELOPMENT AND THE PRICE THAT COMES WITH IT

Big cities like Bengaluru are losing their soul. The priorities we chase are about brick, mortar, money, growth and what falls under the crass umbrella of the \"development\" word

4 mins read
The Morning Standard
January 17, 2023

rhythms of bengaluru

The Garden City has a charm like no other; you can go park hopping or pub hopping depending on what time of the day it is, or what the mood is. Soak in Bengaluru's easy charm with Jayshree Poddar, Deena Rodrigues, Nain Beliappa, Radheesh Shetty, Uma Rao, Kavya Seth and Shruti Jaipuria

10+ mins read
Livingetc India
January 2023

'B'luru-Chennai expressway to be ready by March'24'

New greenfield project being implemented at a cost of ₹17,000 crore, says Nitin Gadkari

1 min read
The New Indian Express
January 06, 2023

Zip from B'luru to Chennai in 2.15 hrs by 2024: Gadkari

FROM March 2024, people can zip from Bengaluru to Chennai in 2 hours 15 minutes at a speed of 120km/hour, Union Transport Minister Nitin Gadkari said on Thursday, after inspecting the progress of the new 8-lane, 262-km Bengaluru-Chennai Expressway at Vadaganahalli, on the outskirts of Bengaluru.

1 min read
The Morning Standard
January 06, 2023